";s:4:"text";s:4747:" Studie: SARS-CoV-2 kann auch Gehirnzellen angreifenSARS-CoV-2: Wie Infektionen im Krankenhaus vermieden werden könnenOvarial-, Mamma-, Bronchialkarzinom: Neue Daten zur Paclitaxel-Therapie The information presented here is manufacturer recommended dosing. Applies to the following strengths: 10 mg; 20 mg; 50 mg; 150 mg; 2 mg/mL; 75 mg; 100 mgNOTE: Several dosage regimens exist for this drug. The information presented here is manufacturer recommended dosing. The information presented here is manufacturer recommended dosing. The number of patients who completed chemotherapy was higher in those receiving AC 60/600 than in those receiving AC 40/500 (91.9% vs 99.1%, p = 0.026).
Atypon Jika digunakan sebagai satu-satunya obat: 60-75 miligram (mg)/m2 IV selama 3-10 menit setiap 21 hari sekali. The information presented here is manufacturer recommended dosing. This site needs JavaScript to work properly. Always consult institutional protocol.NOTE: Several dosage regimens exist for this drug. 1988;4(1):53-8. doi: 10.1002/ssu.2980040111.Gulia A, Arora RS, Panda PK, Raja A, Tiwari A, Bakhshi S, Salins N, Goel V, Janu A.Indian J Orthop. The probability of developing impaired myocardial function based on a combined index of signs, symptoms and decline in left ventricular ejection fraction (LVEF) is estimated to be 1 to 2% at a total cumulative dose of 300 mg/m2 of doxorubicin, 3 to 5% at a dose of 400 mg/m2, 5 to 8% at 450 mg/m2 and 6 to 20% at 500 mg/m2. Always consult institutional protocol.NOTE: Several dosage regimens exist for this drug. Grade 3/4 neutropenia was frequent in AC 60/600 (6.5% vs 24.3%, p < 0.001). Intravenous dosage. In a phase III non-inferiority trial, 509 patients were randomized to receive PLD 50 mg/m2 IV or doxorubicin (60 mg/m2 IV on day 1, every 3 weeks) until disease progression. Some cancers are more responsive to this drug than others. Jika digunakan bersama dengan obat lain: 40-75 mg/m2 IV setiap 21-28 hari sekali. Always consult institutional protocol.NOTE: Several dosage regimens exist for this drug. The information presented here is manufacturer recommended dosing. Clipboard, Search History, and several other advanced features are temporarily unavailable. Available for Android and iOS devices. We comply with the HONcode standard for trustworthy health information - Always consult institutional protocol.NOTE: Several dosage regimens exist for this drug. The information presented here is manufacturer recommended dosing. Sunmedia PierOnline
Always consult institutional protocol.NOTE: Several dosage regimens exist for this drug. Some cancers are more responsive to this drug than others. Jika digunakan bersama dengan obat lain: 40-75 mg/m2 IV setiap 21-28 hari sekali. 2019 Nov 14;2(Suppl 1):i40-i49. The information presented here is manufacturer recommended dosing. doi: 10.1093/noajnl/vdz047. For the treatment of metastatic breast cancer. The NSABP B-15 study: the combination dosage regimen of doxorubicin 60 mg/m2 and cyclophosphamide 600 mg/m2 was done on day 1 of each 21-day treatment cycle. Anan K, Mitsuyama S, Taniguchi H, Yamamoto Y, Fujiyoshi K, Tateishi T, Tamura K.Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN.Int J Radiat Oncol Biol Phys. Name must be less than 100 characters